Zhan P - Search Results

1

Covalently Targeted Highly Conserved Tyr318 to Improve the Drug Resistance Profiles of HIV-1 NNRTIs: A Proof-of-Concept Study.

Zhou Z, Meng B, An J, Zhao F, Sun Y, Zeng D, Wang W, Gao S, Xia Y, Dun C, De Clercq E, Pannecouque C, Zhan P, Kang D, Liu X. Zhou Z, et al. Among authors: zhan p. Int J Mol Sci. 2023 Jan 7;24(2):1215. doi: 10.3390/ijms24021215. Int J Mol Sci. 2023. PMID: 36674730 Free PMC article.

2

Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.

Liu XY, Yan RZ, Wang Y, Zhan P, De Clercq E, Pannecouque C, Witvrouw M, Molina MT, Vega S. Liu XY, et al. Among authors: zhan p. Arch Pharm (Weinheim). 2008 Apr;341(4):216-22. doi: 10.1002/ardp.200700216. Arch Pharm (Weinheim). 2008. PMID: 18266290

3

Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives.

Zhan P, Liu X, De Clercq E. Zhan P, et al. Curr Med Chem. 2008;15(15):1529-40. doi: 10.2174/092986708784638898. Curr Med Chem. 2008. PMID: 18537628 Review.

4

1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

Zhan P, Liu X, Cao Y, Wang Y, Pannecouque C, De Clercq E. Zhan P, et al. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5368-71. doi: 10.1016/j.bmcl.2008.09.055. Epub 2008 Sep 18. Bioorg Med Chem Lett. 2008. PMID: 18824350

5

Recent advances in the research of HIV-1 RNase H inhibitors.

Yu F, Liu X, Zhan P, De Clercq E. Yu F, et al. Among authors: zhan p. Mini Rev Med Chem. 2008 Oct;8(12):1243-51. doi: 10.2174/138955708786141052. Mini Rev Med Chem. 2008. PMID: 18855738 Review.

6

Designed multiple ligands: an emerging anti-HIV drug discovery paradigm.

Zhan P, Liu X. Zhan P, et al. Curr Pharm Des. 2009;15(16):1893-917. doi: 10.2174/138161209788453266. Curr Pharm Des. 2009. PMID: 19519431 Review.

7

Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs.

Zhan P, Li Z, Liu X, De Clercq E. Zhan P, et al. Mini Rev Med Chem. 2009 Jul;9(8):1014-23. doi: 10.2174/138955709788681618. Mini Rev Med Chem. 2009. PMID: 19601897 Review.

8

Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.

Zhan P, Liu X, Li Z, Fang Z, Li Z, Wang D, Pannecouque C, Clercq ED. Zhan P, et al. Bioorg Med Chem. 2009 Aug 15;17(16):5920-7. doi: 10.1016/j.bmc.2009.07.004. Epub 2009 Jul 7. Bioorg Med Chem. 2009. PMID: 19620009

9

Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Zhan P, Liu X, Fang Z, Li Z, Pannecouque C, De Clercq E. Zhan P, et al. Eur J Med Chem. 2009 Nov;44(11):4648-53. doi: 10.1016/j.ejmech.2009.06.037. Epub 2009 Jul 4. Eur J Med Chem. 2009. PMID: 19628308

10

Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.

Zhan P, Liu X, Zhu J, Fang Z, Li Z, Pannecouque C, Clercq ED. Zhan P, et al. Bioorg Med Chem. 2009 Aug 15;17(16):5775-81. doi: 10.1016/j.bmc.2009.07.028. Epub 2009 Jul 18. Bioorg Med Chem. 2009. PMID: 19643613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

980 results

Search Page

Filters